---
{"dg-publish":true,"permalink":"/pages/Pre-op paediatric assessment/"}
---


202406232326

Status: 

Tags: [[Knowledge/Medicine/Paediatrics\|Paed]]

# Pre-op paediatric assessment




Syndromes associated with difficult airways

|Syndrome|Abnormalities|Difficult mask ventilation/intubation|
|---|---|---|
|Apert syndrome|Midface hypoplasia|Mask ventilation|
|Beckwith Wiederman syndrome|Macroglossia|Both|
|Crouzon syndrome|Midface hypoplasia|Mask ventilation|
|Downs syndrome|Macroglossia, brachycephaly, atlanto-axial instability|Both|
|Goldenhar syndrome|Midface/hemifacial hypoplasia|Intubation|
|Mucopolysaccharidoses, e.g. Hurler's/Hunter's syndrome|Macroglossia, craniofacial abnormality, temporomandibular joint dysfunction adenoid and tonsil hypertrophy|Both|
|Klippel–Feil syndrome|Cervical fusion|Intubation|
|Pierre Robin syndrome|Micrognathia, retrognathia|Intubation|
|Treacher Collins syndrome|Micrognathia|Intubation|

Syndromes associated with congenital heart disease

| **Syndrome**                         | **Associated cardiac anomalies**                                                                        |
| ------------------------------------ | ------------------------------------------------------------------------------------------------------- |
| Down syndrome (trisomy 21)           | Atrioventricular septal defects, atrial septal defects, ventricular septal defects, tetralogy of Fallot |
| Turner syndrome (45X)                | Coarctation of the aorta, bicuspid aortic valve, aortic stenosis                                        |
| DiGeorge syndrome (22q11.2 deletion) | Tetralogy of Fallot, aortic arch abnormalities, truncus arteriosus                                      |
| Noonan syndrome (RAS-MPK)            | Pulmonary stenosis, atrial septal defect, hypertrophic cardiomyopathy                                   |
| Williams syndrome (7q11.23)          | Aortic stenosis, peripheral pulmonary stenosis                                                          |

Premed

| Drug        | Dose (oral unless stated otherwise) | Onset         | Comments                                                                      |
| ----------- | ----------------------------------- | ------------- | ----------------------------------------------------------------------------- |
| Midazolam   | 0.5 mg/kg                           | 20–30 minutes | Risk of paradoxical excitement                                                |
| Lorazepam   | 50–100 micrograms/kg                | 30–60 minutes | Risk of prolonged sedation (up to 6 hours)                                    |
| Clonidine   | 2–4 micrograms/kg                   | 30–60 minutes | Unfavourable cardiovascular effects                                           |
| Ketamine    | 2–8 mg/kg                           | 30–40 minutes | Nurse in a quiet, calm environment. Emergent hallucinations may be unpleasant |
| Diamorphine | 0.1 mg/kg intranasal                | 15–30 minutes | Mild, early stinging sensation                                                |


Summary of the general recommendations for the perioperative management of patients with neuromuscular disorders

| Perioperative domain        | Recommendation                                                                    | Explanation                                                                                                            |
| --------------------------- | --------------------------------------------------------------------------------- | ---------------------------------------------------------------------------------------------------------------------- |
| Surgical setting            | 24-hour high care facility available                                              | Poor respiratory reserve and high risk of complications.                                                               |
| Preoperative assessment     | Multidisciplinary team involvement                                                | Complexity of patient                                                                                                  |
| Anaesthetic technique       | Regional anaesthesia ± general anaesthesia                                        | Minimize risk of complications, e.g respiratory depression                                                             |
| Preoperative fasting        | - Schedule as first case<br>- Gastric ultrasound                                  | Risk of hypoglycaemia  <br>Risk of gastric dysmotility                                                                 |
| Body temperature management | Use preoperative warming techniques                                               | Vulnerable to hypothermia                                                                                              |
| General anaesthesia         | Short-acting agents                                                               | Minimize respiratory depression                                                                                        |
| Neuromuscular blockers      | - Avoid suxamethonium                                                             | - Risk of hyperkalaemia                                                                                                |
|                             | - Reduce dose of non-depolarizing muscle relaxant                                 | - Increased sensitivity                                                                                                |
|                             | - Use sugammadex                                                                  | - Sensitive to residual blockade                                                                                       |
|                             | - Use quantitative train-of-four monitoring                                       |                                                                                                                        |
| Volatile anaesthetics       | Avoid prolonged use                                                               | RYR1 diseases – malignant hyperthermia (absolute contraindication)  <br>Muscular dystrophy – rhabdomyolysis (relative) |
| Propofol                    | Use total intravenous anaesthesia  <br>_However caution in mitochondrial disease_ | Risk of propofol infusion syndrome in mitochondrial disease                                                            |
| Postoperative               | Monitor for 24 hours                                                              | Respiratory depression  <br>Rhabdomyolysis                                                                             |
|                             | Enhanced recovery pathway                                                         | Reduced complications                                                                                                  |
|                             | Medical alert card                                                                | Patient safety                                                                                                         |




___
# References
